186 related articles for article (PubMed ID: 30074440)
21. Small cells in hepatoblastoma lack "oval" cell phenotype.
Badve S; Logdberg L; Lal A; de Davila MT; Greco MA; Mitsudo S; Saxena R
Mod Pathol; 2003 Sep; 16(9):930-6. PubMed ID: 13679457
[TBL] [Abstract][Full Text] [Related]
22. β-Catenin mutations in 2 nested stromal epithelial tumors of the liver--a neoplasia with defective mesenchymal-epithelial transition.
Assmann G; Kappler R; Zeindl-Eberhart E; Schmid I; Häberle B; Graeb C; Jung A; Müller-Höcker J
Hum Pathol; 2012 Nov; 43(11):1815-27. PubMed ID: 22749188
[TBL] [Abstract][Full Text] [Related]
23. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas.
Wei Y; Fabre M; Branchereau S; Gauthier F; Perilongo G; Buendia MA
Oncogene; 2000 Jan; 19(4):498-504. PubMed ID: 10698519
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the continuous cell line HepT1 derived from a human hepatoblastoma.
Pietsch T; Fonatsch C; Albrecht S; Maschek H; Wolf HK; von Schweinitz D
Lab Invest; 1996 Apr; 74(4):809-18. PubMed ID: 8606490
[TBL] [Abstract][Full Text] [Related]
25. Hepatocyte growth-factor-scatter factor can stimulate post-operative tumor-cell proliferation in childhood hepatoblastoma.
von Schweinitz D; Faundez A; Teichmann B; Birnbaum T; Koch A; Hecker H; Glüer S; Fuchs J; Pietsch T
Int J Cancer; 2000 Jan; 85(2):151-9. PubMed ID: 10629070
[TBL] [Abstract][Full Text] [Related]
26. Low expression of N-myc downstream-regulated gene 2 (NDRG2) correlates with poor prognosis in hepatoblastoma.
Gödeke J; Luxenburger E; Trippel F; Becker K; Häberle B; Müller-Höcker J; von Schweinitz D; Kappler R
Hepatol Int; 2016 Mar; 10(2):370-6. PubMed ID: 26646663
[TBL] [Abstract][Full Text] [Related]
27. Activated NOTCH2 is overexpressed in hepatoblastomas: an immunohistochemical study.
Litten JB; Chen TT; Schultz R; Herman K; Comstock J; Schiffman J; Tomlinson GE; Rakheja D
Pediatr Dev Pathol; 2011; 14(5):378-83. PubMed ID: 21639801
[TBL] [Abstract][Full Text] [Related]
28. Thymosin β4 promotes hepatoblastoma metastasis via the induction of epithelial-mesenchymal transition.
Fu X; Cui P; Chen F; Xu J; Gong L; Jiang L; Zhang D; Xiao Y
Mol Med Rep; 2015 Jul; 12(1):127-32. PubMed ID: 25695679
[TBL] [Abstract][Full Text] [Related]
29. Targeting long non-coding RNA-TUG1 inhibits tumor growth and angiogenesis in hepatoblastoma.
Dong R; Liu GB; Liu BH; Chen G; Li K; Zheng S; Dong KR
Cell Death Dis; 2016 Jun; 7(6):e2278. PubMed ID: 27362796
[TBL] [Abstract][Full Text] [Related]
30. In vitro gene targeting in human hepatoblastoma.
Warmann SW; Armeanu S; Frank H; Buck H; Graepler F; Lemken ML; Heitmann H; Seitz G; Lauer UM; Bitzer M; Fuchs J
Pediatr Surg Int; 2006 Jan; 22(1):16-23. PubMed ID: 16374644
[TBL] [Abstract][Full Text] [Related]
31. Cytogenetic analysis of hepatoblastoma: hypothesis of cytogenetic evolution in such tumors and results of a multicentric study.
Sainati L; Leszl A; Stella M; Montaldi A; Perilongo G; Rugge M; Bolcato S; Iolascon A; Basso G
Cancer Genet Cytogenet; 1998 Jul; 104(1):39-44. PubMed ID: 9648556
[TBL] [Abstract][Full Text] [Related]
32. GATA4 is upregulated in nasopharyngeal cancer and facilitates epithelial-mesenchymal transition and metastasis through regulation of
Zhou Y; Chang H; Yang B
Exp Ther Med; 2018 Dec; 16(6):5318-5326. PubMed ID: 30542490
[TBL] [Abstract][Full Text] [Related]
33. Small cell undifferentiated (SCUD) hepatoblastomas: All malignant rhabdoid tumors?
Vokuhl C; Oyen F; Häberle B; von Schweinitz D; Schneppenheim R; Leuschner I
Genes Chromosomes Cancer; 2016 Dec; 55(12):925-931. PubMed ID: 27356182
[TBL] [Abstract][Full Text] [Related]
34. GATA4 loss of function in liver cancer impedes precursor to hepatocyte transition.
Enane FO; Shuen WH; Gu X; Quteba E; Przychodzen B; Makishima H; Bodo J; Ng J; Chee CL; Ba R; Seng Koh L; Lim J; Cheong R; Teo M; Hu Z; Ng KP; Maciejewski J; Radivoyevitch T; Chung A; Ooi LL; Tan YM; Cheow PC; Chow P; Chan CY; Lim KH; Yerian L; Hsi E; Toh HC; Saunthararajah Y
J Clin Invest; 2017 Sep; 127(9):3527-3542. PubMed ID: 28758902
[TBL] [Abstract][Full Text] [Related]
35. Targeting LRH‑1 in hepatoblastoma cell lines causes decreased proliferation.
Jin J; Jin J; Woodfield SE; Patel RH; Jin NG; Shi Y; Liu B; Sun W; Chen X; Yu Y; Vasudevan SA
Oncol Rep; 2019 Jan; 41(1):143-153. PubMed ID: 30320362
[TBL] [Abstract][Full Text] [Related]
36. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M
Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019
[TBL] [Abstract][Full Text] [Related]
37. Analysis of CDKN2A, CDKN2B, CDKN2C, and cyclin Ds gene status in hepatoblastoma.
Iolascon A; Giordani L; Moretti A; Basso G; Borriello A; Della Ragione F
Hepatology; 1998 Apr; 27(4):989-95. PubMed ID: 9537438
[TBL] [Abstract][Full Text] [Related]
38. Gene expression profiling reveals signatures characterizing histologic subtypes of hepatoblastoma and global deregulation in cell growth and survival pathways.
Adesina AM; Lopez-Terrada D; Wong KK; Gunaratne P; Nguyen Y; Pulliam J; Margolin J; Finegold MJ
Hum Pathol; 2009 Jun; 40(6):843-53. PubMed ID: 19200578
[TBL] [Abstract][Full Text] [Related]
39. Expression levels of insulin-like growth factor binding proteins and insulin receptor isoforms in hepatoblastomas.
von Horn H; Tally M; Hall K; Eriksson T; Ekström TJ; Gray SG
Cancer Lett; 2001 Jan; 162(2):253-60. PubMed ID: 11146233
[TBL] [Abstract][Full Text] [Related]
40. The presence of PIM3 increases hepatoblastoma tumorigenesis and tumor initiating cell phenotype and is associated with decreased patient survival.
Stafman LL; Waldrop MG; Williams AP; Aye JM; Stewart JE; Mroczek-Musulman E; Yoon KJ; Whelan K; Beierle EA
J Pediatr Surg; 2019 Jun; 54(6):1206-1213. PubMed ID: 30898394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
